首页> 外文期刊>Digestive surgery >Evaluation of Combined Argon Plasma Coagulation and Savary Bougienage for the Relief of Anastomotic-Stenosis after Esophageal Squamous Cancer Surgery
【24h】

Evaluation of Combined Argon Plasma Coagulation and Savary Bougienage for the Relief of Anastomotic-Stenosis after Esophageal Squamous Cancer Surgery

机译:食管鳞癌手术后联合氩气血浆凝集和美味紫菜汤对吻合口狭窄的缓解作用

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Several endoscopic dilation techniques have been reported for treatment of anastomotic-stenosis of esophageal cancer, but the high incidence of dysphagia has remained unchanged. The aim of this study was to compare the effect of Argon Plasma Coagulation (APC) combined with Savary Bougienage (SB) compared to APC alone or SB alone for anastomotic-stenosis after radical operation for squamous cell carcinoma of the esophagus. Methods: Patients with anastomotic-stenosis that was diagnosed for the first time following esophageal squamous cell carcinoma resection surgery were randomly assigned to undergo APC combined with SB, APC alone, or SB alone. Primary endpoints were the dysphagia-free survival (DFS defined as the time from first dilatation of effectively relieved dysphagia to dysphagia relapse expressed in days) after 6 months of follow up. Results: A total of 90 patients from the Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology were entered into the study (APC group, n = 30, SB group, n = 30, combination group [APC combined with SB], n = 30). Primary endpoints: 6 months after treatment, DFS of combination group (115.63 days; 95% CI, 105.31-125.95) was significantly longer than the APC alone group (39.53 days; 95% CI, 35.95-43.11, p = 0.000) and the SB alone group (16.93 days; 95% CI, 15.01-18.84, p = 0.000). No severe complications occurred within the three treatment groups. Conclusions: APC combined with SB was a safe and well-tolerated method for relieving dysphagia of esophageal squamous cell cancer patients with anastomotic-stenosis. (Registered with randomized controlled trials, ChiCRT, registration number ChiCTR-TRC-13003757.) (C) 2015 S. Karger AG, Basel
机译:背景:已经报道了几种内窥镜扩张技术来治疗食管癌吻合口狭窄,但是吞咽困难的高发率一直没有改变。这项研究的目的是比较食管鳞状细胞癌根治术后与单独使用APC或单独使用SB相比,氩等离子体凝结(APC)结合Savary Bougienage(SB)的效果。方法:将在食管鳞状细胞癌切除手术后首次被诊断为吻合口狭窄的患者随机分为APC联合SB,单独APC或单独SB。主要终点是随访6个月后无吞咽困难的生存期(DFS定义为从有效缓解的吞咽困难的第一次扩张到吞咽困难复发的时间(以天为单位))。结果:来自河南科技大学第一附属医院肿瘤研究所的90例患者进入研究(APC组,n = 30,SB组,n = 30,联合组[APC联合SB] ,n = 30)。主要终点:治疗后6个月,联合治疗组的DFS(115.63天; 95%CI,105.31-125.95)显着长于单独APC组(39.53天; 95%CI,35.95-43.11,p = 0.000),并且单独SB组(16.93天; 95%CI,15.01-18.84,p = 0.000)。三个治疗组内均未发生严重并发症。结论:APC联合SB治疗食管鳞状细胞癌吻合口狭窄患者吞咽困难是一种安全,耐受的方法。 (在随机对照试验中注册,ChiCRT,注册号ChiCTR-TRC-13003757。)(C)2015 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号